|1.||Muttukrishna, S: 10 articles (07/2011 - 02/2000)|
|2.||Lambert-Messerlian, G M: 7 articles (05/2008 - 04/2000)|
|3.||Groome, N: 7 articles (10/2007 - 07/2000)|
|4.||Palomaki, Glenn E: 6 articles (08/2015 - 08/2006)|
|5.||Petraglia, Felice: 6 articles (11/2008 - 04/2002)|
|6.||Petraglia, F: 6 articles (02/2003 - 05/2000)|
|7.||Groome, N P: 6 articles (11/2002 - 02/2000)|
|8.||Neveux, Louis M: 5 articles (08/2015 - 08/2006)|
|9.||Canick, Jacob A: 5 articles (12/2009 - 09/2002)|
|10.||Lambert-Messerlian, Geralyn M: 5 articles (12/2009 - 09/2002)|
06/01/2001 - "The improvement in sensitivity for the combined method, compared to either inhibin-A or uterine artery Dopplers alone, was statistically significant for both pre-eclampsia ( P < 0.05) and preterm pre-eclampsia ( P < 0.02). "
06/01/2001 - "To evaluate the screening efficacy of second-trimester maternal serum inhibin-A combined with uterine artery Doppler studies performed at 20 weeks' gestation for the prediction of pre-eclampsia. "
06/01/2001 - "Combination of second-trimester serum inhibin-A and uterine artery Doppler at 20 weeks improves the screening efficacy for the prediction of pre-eclampsia especially when this necessitates early delivery. "
06/01/2001 - "For pre-eclampsia requiring delivery before 37 weeks for a false-positive rate of 3%, the sensitivity for bilateral notches improved from 27% to 60% and the positive likelihood ratio improved from 9.2 to 20.8 when uterine artery notch data was combined with inhibin-A. "
06/01/2001 - "Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler."
|2.||Down Syndrome (Down's Syndrome)
11/01/2006 - "Seventy-nine matched case-control sets of maternal serum samples (each Down syndrome case matched to 5 controls) from 11 through 13 completed weeks of gestation were taken from the sample bank of the First and Second Trimester Evaluation of Risk Consortium, a population-based study, and assayed for levels of free beta-hCG, total hCG, and inhibin A. "
04/01/2004 - "Several studies report the role of dimeric inhibin-A in assessing risk for fetal Down syndrome. "
06/01/2000 - "Native Japanese dimeric inhibin A median values in this study are 1.77 times higher in Down's syndrome cases than in unaffected pregnancies. "
03/01/1998 - "The aim of this study was to evaluate the additional value of dimeric inhibin-A serum concentration in second trimester multiple-marker screening tests for pregnancies affected by Down's syndrome. "
04/01/2014 - "Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome."
04/01/2000 - "Serum and peritoneal fluid inhibin A, B, and pro-alphaC concentrations, and serum FSH and tumor marker CA 125 (study group only) concentrations were analyzed. "
05/01/2004 - "Inhibin A levels in cyst fluid from epithelial ovarian tumors."
08/01/2000 - "Dimeric inhibin A production may be the result of combined efforts of the tumor stroma (alpha subunit) and epithelium (betaA subunit). "
04/01/2000 - "To compare serum and peritoneal fluid concentrations of inhibin A, B, and pro-alphaC in women with ovarian tumors. "
04/01/2000 - "Inhibin A, B and pro-alphaC in serum and peritoneal fluid in postmenopausal patients with ovarian tumors."
|4.||Granulosa Cell Tumor
01/01/2013 - "In addition, the patient had elevated inhibin A and B levels, which may be elevated in granulosa cell tumor. "
05/01/2007 - "In 30 consecutive patients with a stage I-III granulosa cell tumor, inhibin A and B concentrations were measured in pre- and post-treatment serum samples. "
05/01/2007 - "Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort."
03/01/1998 - "Only one of eight patients with a progressive granulosa cell tumor had a high value of serum inhibin A. "
03/01/1999 - "Previous studies have shown that serum inhibin as measured by alpha subunit-directed radioimmunoassay (RIA) and inhibin A ELISA was elevated in postmenopausal women with mucinous and granulosa cell cancers, with the RIA showing a more frequent elevation than the inhibin A ELISA. "
01/01/2004 - "In the second trimester, assessment of maternal inhibin A levels has been shown to improve sensitivity of the existing serum screening tests for aneuploid pregnancies and made prove clinically useful in the early detection of pregnancies susceptible to developing pre-eclampsia. "
08/01/1999 - "Inhibin A and non-Down syndrome aneuploidy."
10/01/1999 - "Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection."
10/01/1999 - "Our goal was to prospectively evaluate the use of the free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for the detection of fetal Down syndrome and other aneuploidies. "
10/01/1998 - "Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome."
|2.||Chorionic Gonadotropin (Human Chorionic Gonadotropin)
|7.||Pregnancy-Associated Plasma Protein-A (PAPP-A)
|8.||Biological Markers (Surrogate Marker)
|1.||Drug Therapy (Chemotherapy)
|3.||Cesarean Section (Caesarean Section)